When will we know enough to treat atrial fibrillation?

被引:3
作者
Anderson, Mark E. [1 ]
机构
[1] Univ Iowa, Carver Coll Med, Div Cardiovasc Dis, Iowa City, IA 52242 USA
关键词
NF-KAPPA-B; ANGIOTENSIN-II; ARRHYTHMIAS; GROWTH;
D O I
10.1016/j.hrthm.2007.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:750 / 751
页数:2
相关论文
共 13 条
[1]  
[Anonymous], CIRCULATION
[2]   Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts [J].
Bartunek, J ;
Weinberg, EO ;
Tajima, M ;
Rohrbach, S ;
Lorell, BH .
CIRCULATION, 1999, 99 (01) :22-25
[3]   C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].
Chung, MK ;
Martin, DO ;
Sprecher, D ;
Wazni, O ;
Kanderian, A ;
Carnes, CA ;
Bauer, JA ;
Tchou, PJ ;
Niebauer, MJ ;
Natale, A ;
Van Wagoner, DR .
CIRCULATION, 2001, 104 (24) :2886-2891
[4]   Potymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation [J].
Darbar, Dawood ;
Motsinger, Alison A. ;
Ritchie, Marylyn D. ;
Gainer, James V. ;
Roden, Dan M. .
HEART RHYTHM, 2007, 4 (06) :743-749
[5]   Cardiac aldosterone production and ventricular remodeling [J].
Delcayre, C ;
Silvestre, JS ;
Garnier, A ;
Oubenaissa, A ;
Cailmail, S ;
Tatara, E ;
Swynghedauw, B ;
Robert, V .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1346-1351
[6]   MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo [J].
Lips, DJ ;
Bueno, OF ;
Wilkins, BJ ;
Purcell, NH ;
Kaiser, RA ;
Lorenz, JN ;
Voisin, L ;
Saba-El-Leil, MK ;
Meloche, S ;
Pouysségur, J ;
Pagès, G ;
De Windt, LJ ;
Doevendans, PA ;
Molkentin, JD .
CIRCULATION, 2004, 109 (16) :1938-1941
[7]   NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats [J].
Muller, DN ;
Dechend, R ;
Mervaala, EMA ;
Park, JK ;
Schmidt, F ;
Fiebeler, A ;
Theuer, J ;
Breu, V ;
Ganten, D ;
Haller, H ;
Luft, FC .
HYPERTENSION, 2000, 35 (01) :193-201
[8]   ASYMPTOMATIC ARRHYTHMIAS IN PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA [J].
PAGE, RL ;
WILKINSON, WE ;
CLAIR, WK ;
MCCARTHY, EA ;
PRITCHETT, ELC .
CIRCULATION, 1994, 89 (01) :224-227
[9]   Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction [J].
Perrier, E ;
Kerfant, BG ;
Lalevee, N ;
Bideaux, P ;
Rossier, MF ;
Richard, S ;
Gómez, AM ;
Benitah, JP .
CIRCULATION, 2004, 110 (07) :776-783
[10]   Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes [J].
Purcell, NH ;
Tang, GL ;
Yu, CF ;
Mercurio, F ;
DiDonato, JA ;
Lin, AN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6668-6673